without the patent owner's authorization by issuing a compulsory license (CL). In the pharmaceuticals space, governments have … before patent expiry, increasing the supply and reducing the price of patented pharmaceuticals domestically. This paper … evaluates the three primary barriers to employing compulsory licenses for pharmaceuticals underscored by members during TRIPS …